News
10-19-2010, 06:40 AM
Agendia, a world leader in molecular cancer diagnostics, announced today that it has established a contract with leading insurance provider Humana to reimburse for the company's MammaPrint test. Agendia's contract with Humana expands the coverage for MammaPrint by more than 17 million lives. In November 2009, Palmetto GBA, California's Part B Medicare administrator, established coding guidelines for MammaPrint, allowing healthcare providers from across the United States to submit claims for the test.
More... (http://www.news-medical.net/news/20101019/Agendia-establishes-contract-with-Humana-for-coverage-of-MammaPrint-breast-cancer-recurrence-test.aspx)
More... (http://www.news-medical.net/news/20101019/Agendia-establishes-contract-with-Humana-for-coverage-of-MammaPrint-breast-cancer-recurrence-test.aspx)